Towards the safer use of warfarin I: An overview

Research output: Contribution to journalReview articlepeer-review

17 Citations (Scopus)


There has been an exponential increase of warfarin usage in the community since several large and well-designed clinical trials have consistently found that warfarin can safely prevent embolic stroke in people with atrial fibrillation. Safe and effective warfarin treatment requires a case-by-case evaluation of each patient's clinical condition and risk factors for bleeding. It also demands a therapeutic partnership where patients can accept an educated responsibility for managing their own condition. This requires mutually understood plans for ongoing management, including dose adjustment and responses to under- or overdose and to bleeding complications.

Original languageEnglish
Pages (from-to)55-59
Number of pages5
JournalJournal of Quality in Clinical Practice
Issue number1
Publication statusPublished - Mar 1999
Externally publishedYes


  • Anticoagulant
  • Bleeding risk
  • Patient education
  • Warfarin therapy


Dive into the research topics of 'Towards the safer use of warfarin I: An overview'. Together they form a unique fingerprint.

Cite this